Skip to main content

Full Schedule

Full Schedule

  • Friday, August 4, 2023
  • 9:00 AM – 9:15 AM ET
    Welcome
  • 9:15 AM – 9:30 AM ET
    18 - Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - FOLFIRINOX
  • 9:30 AM – 9:45 AM ET
    18 - Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOX
  • 9:45 AM – 10:00 AM ET
    18 - Session 15: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer
  • 10:00 AM – 10:15 AM ET
    Break
  • 10:15 AM – 10:30 AM ET
    15 - Session 16: Debate: Is There a Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Yes
  • 10:30 AM – 10:45 AM ET
    15 - Session 16: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - No
  • 10:45 AM – 11:00 AM ET
    15 - Session 16: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Discussion
  • 11:00 AM – 11:15 AM ET
    Break
  • 11:15 AM – 11:50 AM ET
    19 - Session 17: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment Strategies
  • 11:50 AM – 12:00 PM ET
    19 - Live Q&A
  • 12:15 PM – 12:30 PM ET
    Break
  • 12:30 PM – 1:05 PM ET
    21 - Session 18: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
  • 1:05 PM – 1:15 PM ET
    21 - Live Q&A
  • 1:15 PM – 1:30 PM ET
    Break
  • 1:30 PM – 2:15 PM ET
    Session 19: Determination of Treatment Patterns in HCC
    Presenter: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
  • 2:15 PM – 2:30 PM ET
    Break
  • 2:30 PM – 3:15 PM ET
    Session 20: Role of Interventional Radiology in the Management of NETs
    Presenter: Nishita Kothary, MD – Stanford School of Medicine
  • 3:15 PM – 3:30 PM ET
    Break
  • 3:30 PM – 4:15 PM ET
    20 - Session 21: Significance of Cancer Genetics
  • 4:15 PM – 4:20 PM ET
    20 - Closing Remarks